New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria

Antibiotic resistance in medically relevant bacterial pathogens, coupled with a paucity of novel antimicrobial discoveries, represents a pressing global crisis. Traditional drug discovery is an inefficient and costly process; however, systematic screening of Food and Drug Administration (FDA)-approv...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Andersson, Jourdan A., Fitts, Eric C., Kirtley, Michelle L., Ponnusamy, Duraisamy, Peniche, Alex G., Dann, Sara M., Motin, Vladimir L., Chauhan, Sadhana, Rosenzweig, Jason A., Sha, Jian, Chopra, Ashok K.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2016
Sujets:
Experimental Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879411/
https://ncbi.nlm.nih.gov/pubmed/27067323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00326-16
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires